VISIOTACT PHARMA has a total of 20 patent applications. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and foods and drinks are EMMAUS MEDICAL INC, GUANGXI HERBAL MEDICINE HEALTH PRODUCTS CO LTD and QUE FENG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Canada | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Brazil | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 | |
#7 | Mexico | 1 | |
#8 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Foods | |
#4 | Special foods | |
#5 | Cocoa and sweets |
# | Name | Total Patents |
---|---|---|
#1 | Hadj-Slimane Reda | 16 |
#2 | Lepelletier Yves | 11 |
#3 | Hadj-Slimane Tewfik | 8 |
#4 | Hadj-Slimane Réda | 2 |
#5 | Reda Hadj-Slimane | 2 |
#6 | Tewfik Hadj-Slimane | 1 |
#7 | Yves Lepelletier | 1 |
#8 | Hadj-Sliman Tewfik | 1 |
Publication | Filing date | Title |
---|---|---|
CA2812999A1 | Composition comprising sod, lutein and zeaxanthin | |
EP2567689A1 | Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid | |
EP2476425A1 | Composition comprising OPC and Omega-3 for preventing and/or inhibiting the development of diabetic retinopathy | |
EP2417967A1 | A transmucosal composition containing anthocyanins for alleviating a visual discomfort |